773 related articles for article (PubMed ID: 11436505)
1. [Sentinel lymph node (SLN) in breast cancer: prediction of axillary metastasis confined to the SLN spares patients further axillary dissection].
Sato K; Hiraide H; Mochizuki H
Nihon Geka Gakkai Zasshi; 2001 Jun; 102(6):445-8. PubMed ID: 11436505
[TBL] [Abstract][Full Text] [Related]
2. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.
Saidi RF; Dudrick PS; Remine SG; Mittal VK
Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910
[TBL] [Abstract][Full Text] [Related]
3. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.
Rivers AK; Griffith KA; Hunt KK; Degnim AC; Sabel MS; Diehl KM; Cimmino VM; Chang AE; Lucas PC; Newman LA
Ann Surg Oncol; 2006 Jan; 13(1):36-44. PubMed ID: 16378156
[TBL] [Abstract][Full Text] [Related]
5. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
6. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
Port ER; Patil S; Stempel M; Morrow M; Cody HS
Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
8. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
10. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
[TBL] [Abstract][Full Text] [Related]
12. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic tumor burden negatively impacts the ability to detect the sentinel lymph node in breast cancer.
Vargas HI; Vargas MP; Venegas R; Gonzalez KD; Burla M; Mishkin F; Khalkhali I
Am Surg; 2003 Oct; 69(10):886-90. PubMed ID: 14570368
[TBL] [Abstract][Full Text] [Related]
14. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N
Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
[TBL] [Abstract][Full Text] [Related]
15. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node.
Wada N; Imoto S; Yamauchi C; Hasebe T; Ochiai A
Eur J Surg Oncol; 2006 Feb; 32(1):29-33. PubMed ID: 16269227
[TBL] [Abstract][Full Text] [Related]
16. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
18. Management strategy of early-stage breast cancer patients with a positive sentinel lymph node: With or without axillary lymph node dissection.
Chen JJ; Wu J
Crit Rev Oncol Hematol; 2011 Sep; 79(3):293-301. PubMed ID: 20663684
[TBL] [Abstract][Full Text] [Related]
19. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients.
Katz A; Niemierko A; Gage I; Evans S; Shaffer M; Smith FP; Taghian A; Magnant C
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):40-4. PubMed ID: 16488555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
